Stay updated on CTX110 in B-Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.
Latest updates to the CTX110 in B-Cell Malignancies Clinical Trial page
- Check4 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check11 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; no visible edits to core study content, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check18 days agoChange Detected- Removed the government funding status notice from the page; study content and data remain unchanged.SummaryDifference0.3%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe Study Record Dates section now shows 'Results First Posted (Estimated)' and 'Last Update Posted (Estimated)' instead of the previous labels. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check39 days agoChange DetectedResults posted on 2025-10-24 for the CTX110 CARBON study include DLT data, objective response rates, survival metrics, SAEs, PK data, and laboratory results through up to 5 years. The plan also removes several long-term endpoints (DOR, DOCB, TFFS, PFS, OS) from the results section.SummaryDifference3%
- Check61 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference4%
Stay in the know with updates to CTX110 in B-Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.